Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2224]

Clues found regarding tumour suppressor gene’s breast cancer activity

Clues found regarding tumour suppressor gene’s breast cancer activity

SABCS 2022: Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after breast-conserving surgery

SABCS 2022: Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after...

SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC

SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced hormone receptor-positive breast cancer

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced...

Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor-positive early-stage breast cancer

SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor...

Single-cell ‘atlas’ reveals origin of an aggressive brain tumor

Single-cell ‘atlas’ reveals origin of an aggressive brain tumor

Research on rare genetic disease sheds light on a common head and neck cancer

Research on rare genetic disease sheds light on a common head and neck cancer

Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern Europe

Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern...

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk...

More from ecancer